NCT03604978 2026-05-13Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III MeningiomaNational Cancer Institute (NCI)Phase 1/2 Active not recruiting38 enrolled